Mycoplasma pneumoniae and chlamydia spp. Infection in community-acquired pneumonia, Germany, 2011–2012

Emerging Infectious Diseases

Volumn 21, Issue 3, 2015, Pages 426-434

  Dumke, Roger ^a   Schnee, Christiane ^b   Pletz, Mathias W ^c,d   Rupp, Jan ^d,e   Jacobs, Enno ^a   Sachse, Konrad ^b   Rohde, Gernot ^a,d,f   Dreher, M ^g   Cornelissen, C ^g   Knuppel W ^h   Armari, I ^h   Stolz, D ⁱ   Suttorp, N ^j   Schutte H ^j   Creutz, P ^j   Bauer, T ^k   Weiss T ^k   Pankow, W ^l   Lies, A ^l   Thiemig, D ^l   Hauptmeier, B ^m   Wehde, D ^m   Suermann, M ^m   Ewig, S ⁿ   Prediger, M ^o   Zernia, G ^o   Hoffken G ^p   Kolditz, M ^p   Welte, T ^q   Barten, G ^r   Abrahamczik, M ^r   Naim, J ^r   Kroner W ^r   Illig, T ^s   Klopp, N ^s   Kroegel, C ^c   Dalhoff, K ^t   Schutz S ^t   Horster R ^t   Rohde, G ^f   Buschmann, H ^u   Kroning R ^u   Schaberg, T ^v   Hering, I ^v   Schumann, C ^w   Illmann, T ^x   Wallner, M ^x   more..

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d CAPNETZ STIFTUNG   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^h Hospital Bad Arolsen   (Germany)

ⁱ Clinic for Pneumology   (Switzerland)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^l Vivantes Clinical Center   (Germany)

^m RUHR UNIVERSITY BOCHUM   (Germany)

ⁿ Augusta Kranken Anstalt   (Germany)

^o CARL THIEM KLINIKUM   (Germany)

^p UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^q HANNOVER MEDICAL SCHOOL   (Germany)

^r Main Office   (Germany)

^s Hannover Unified Biobank   (Germany)

^t UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^u Bruderkrankenhaus St Josef Paderborn   (Germany)

^v Center of Pneumology   (Germany)

^w UNIVERSITY OF ULM   (Germany)

^x 2mt Software GmbH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; RNA 23S;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DNA MICROARRAY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; MULTILOCUS SEQUENCE TYPING; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; TRACHEOBRONCHITIS; VARIABLE NUMBER OF TANDEM REPEAT; ADOLESCENT; CHLAMYDIA; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; GENETICS; GENOTYPE; GERMANY; MICROBIOLOGY; MOLECULAR TYPING; PNEUMONIA, MYCOPLASMA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHLAMYDIA; CHLAMYDIAL PNEUMONIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GENOTYPE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOLECULAR TYPING; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; YOUNG ADULT;

EID: 84928651076     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2103.140927     Document Type: Article

References (41)

1. Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013; 68: 1057–65. http://dx.doi.org/10.1136/ thoraxjnl-2013-204282
2. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67:71–9. http://dx.doi.org/10.1136/thx.2009.129502
3. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplas-ma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956–73. http://dx.doi.org/10.1111/j.1574-6976.2008.00129.x
4. von Baum H, Welte T, Marre R, Suttorp N, Lück C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009; 9:62. http://dx.doi.org/10.1186/1471-2334-9-62
5. Polkowska A, Harjunpää A, Toikkanen S, Lappalainen M, Vuento R, Vuorinen T, et al. Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010–2011. Euro Surveill. 2012;17:20072.
6. Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Molvadgaard M, Fons Petersen R et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 2012;17:20073.
7. Blystad H, Ånestad G, Vestrheim DF, Madsen S, Rønning K. Increased incidence of Mycoplasma pneumoniae infection in Norway 2011. Euro Surveill. 2012;17:20074.
8. Chalker V, Stocki T, Litt D, Bermingham A, Watson J, Fleming D, et al. Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012;17:20081.
9. Linde A, Ternhag A, Torner A, Claesson B. Antibiotic prescriptions and laboratory-confrmed cases of Mycoplasma pneumoniae during the epidemic in Sweden in 2011. Euro Surveill. 2012;17:20082.
10. Nir-Paz R, Abutbul A, Moses AE, Block C, Hidalgo-Grass C. Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill. 2012;17:20095.
11. Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A, Bebear C. The increased incidence of Mycoplasma pneu-moniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. Clin Microbiol Infect.2013;19:E212–7.http://dx.doi.org/10.1111/1469-0691.12107
12. Infectious Disease Surveillance Center. Mycoplasma pneumonia [cited 2014 Aug 31]. http://idsc.nih.go.jp/idwr/kanja/weeklygraph/18myco-e.html
13. Dumke R, von Baum H, Lück PC, Jacobs E. Subtypes and variants of Mycoplasma pneumoniae: local and temporal changes in Germany 2003–2006 and absence of a correlation between the genotype in the respiratory tract and the occurrence of genotype-specifc antibodies in the sera of infected patients. Epidemiol Infect. 2010;138:1829–37. http://dx.doi.org/10.1017/S0950268810000622
14. Dégrange S, Cazanave C, Charron A, Renaudin H, Bebear C, Bebear CM. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol. 2009; 47:914–23. http://dx.doi.org/10.1128/JCM.01935-08
15. Dumke R, von Baum H, Lück PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010; 16: 613–6. http://dx.doi.org/10.1111/j.1469-0691.2009.02968.x
16. Sun H, Xue G, Yan C, Li S, Cao L, Yuan Y, et al. Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS ONE. 2013; 8: e64607. http://dx.doi.org/10.1371/journal.pone.0064607
17. Hammerschlag MR. Chlamydia pneumoniae and the lung. Eur Respir J. 2000; 16: 1001–7. http://dx.doi.org/10.1183/09031936.00.16510010
18. Hahn DL, Azenabor AA, Beatty WL, Byrne GI. Chlamydia pneu-moniae as a respiratory pathogen. Front Biosci. 2002;7:e66–76. http://dx.doi.org/10.2741/hahn
19. Blasi F, Tarsia P, Aliberti S. Chlamydophila pneumoniae. Clin Microbiol Infect. 2009; 15: 29–35. http://dx.doi.org/10.1111/j.1469-0691.2008.02130.x
20. Marrie TJ, Peeling RW, Reid T, De Carolis E. Chlamydia species as a cause of community-acquired pneumonia in Canada.
21. Eur Respir J. 2003;21:779–84. http://dx.doi.org/10.1183/09031936.03.00095403
22. Wellinghausen N, Straube E, Freidank H, von Baum H, Marre R, Essig A. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. Int J Med Microbiol. 2006; 296: 485–91. http://dx.doi.org/10.1016/j.ijmm.2006.05.003
23. Pletz MW, Rohde G, Schutte H, Bals R, von Baum H, Welte T. Epidemiology and aetiology of community-acquired pneumonia (CAP). Dtsch Med Wochenschr. 2011;136:775–80. http://dx.doi.org/10.1055/s-0031-1275806
24. Reinhold P, Sachse K, Kaltenboeck B. Chlamydiaceae in cattle: commensals, trigger organisms, or pathogens? Vet J. 2011;189:257–67. http://dx.doi.org/10.1016/j.tvjl.2010.09.003
25. Welte T, Suttorp N, Marre R. CAPNETZ: Community-Acquired Pneumonia Competence Network. Infection. 2004;32:234–8. http://dx.doi.org/10.1007/s15010-004-3107-z
26. Ehricht R, Slickers P, Goellner S, Hotzel H, Sachse K. Optimized DNA microarray assay allows detection and genotyping of single PCR-amplifable target copies. Mol Cell Probes. 2006;20:60–3. http://dx.doi.org/10.1016/j.mcp.2005.09.003
27. Pantchev A, Sting R, Bauerfeind R, Tyczka J, Sachse K. New real-time PCR tests for species-specifc detection of Chlamydophila psittaci and Chlamydophila abortus from tissue samples. Vet J. 2009;181:145–50. http://dx.doi.org/10.1016/j.tvjl.2008.02.025
28. Sachse K, Hotzel H, Slickers P, Ellinger T, Ehricht R. DNA microarray-based detection and identifcation of Chlamydia and Chlamydophila spp. Mol Cell Probes. 2005;19:41–50. http://dx.doi.org/10.1016/j.mcp.2004.09.005
29. Schnee C, Sachse K. DNA microarray-based detection of multiple pathogens: Mycoplasma spp. and Chlamydia spp. Methods Mol Biol. 2015;1247:193-208.
30. Dumke R, Jacobs E. Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoni-ae. J Clin Microbiol. 2009;47:441–4. http://dx.doi.org/10.1128/JCM.01989-08
31. Dumke R, Lück PC, Noppen C, Schaefer C, von Baum H, Marre R, et al. Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol. 2006;44:2567–70. http://dx.doi.org/10.1128/JCM.00495-06
32. Dumke R, Jacobs E. Culture-independent multi-locus variable-number tandem-repeat analysis (MLVA) of Mycoplasma pneu-moniae. J Microbiol Methods. 2011;86:393–6. http://dx.doi.org/10.1016/j.mimet.2011.06.008
33. Chalker VJ, Stocki T, Mentasti M, Fleming D, Sadler C, Ellis J, et al. Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales. Eur J Clin Microbiol Infect Dis. 2011;30:915–21. http://dx.doi.org/10.1007/s10096-011-1176-3
34. Spuesens EBM, Fraaij PLA, Visser EG, Hoogenboezem T, Hop WCJ, van Adrichem LNA, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10:e1001444. http://dx.doi.org/10.1371/journal.pmed.1001444
35. Zhao F, Cao B, Li J, Song S, Tao X, Yin Y, et al. Sequence analysis of the p1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009. J Clin Microbiol. 2011;49:3000–3. http://dx.doi.org/10.1128/JCM.00105-11
36. Xiao J, Liu Y, Wang M, Jiang C, You X, Zhu C. Detection of Mycoplasma pneumoniae P1 subtype variations by denaturing gradient gel electrophoresis. Diagn Microbiol Infect Dis. 2014;78:24–8. http://dx.doi.org/10.1016/j.diagmicrobio.2013.08.008
37. Benitez AJ, Diaz MH, Wolff BJ, Pimentel G, Njenga MK, Estevez A, et al. Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study. J Clin Microbiol. 2012;50:3620–6. http://dx.doi.org/10.1128/JCM.01755-12
38. Pereyre S, Renaudin H, Charron A, Bebear C. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. Emerg Infect Dis. 2012;18:343–5. http://dx.doi.org/10.3201/eid1802.111379
39. Saegeman V, Proesmans M, Dumke R. Management of macrolide-resistant Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 2012;31:1210–1. http://dx.doi.org/10.1097/INF.0b013e3182611cee
40. Dean D, Kandel RP, Adhikari HK, Hessel T. Multiple Chlamydia-ceae species in trachoma: implications for disease pathogenesis and control. PLoS Med. 2008;5:e14. http://dx.doi.org/10.1371/journal.pmed.0050014
41. Dean D, Rothschild J, Ruettger A, Kandel RP, Sachse K. Zoonotic Chlamydiaceae species associated with trachoma, Nepal. Emerg Infect Dis. 2013;19:1948–55. http://dx.doi.org/10.3201/eid1912.130656